News Takeda's first-in-class narcolepsy drug claims FDA approval Takeda's orexin agonist Orzeyful is the first drug approved in the US that can treat the "full range" of narcolepsy type 1 symptoms, says the FDA.
News Senate confirms Erica Schwartz as CDC Director CDC has a permanent director in place at last, after the Senate confirmed Erica Schwartz's nomination to what has become a politically charged role.
News FDA clears Moderna's mRNA-based seasonal flu shot After a series of regulatory twists and turns, the FDA has approved Moderna's mRNA-based influenza vaccine mFlusiva.
News Sources quash rumours of an AZ/BMS mega-merger A media report suggests there is no substance to the rumours of a $400 billion mega-merger between AstraZeneca and Bristol Myers Squibb.
News Lilly's GLP-1s race away in Q2, though Foundayo falls short Eli Lilly has posted another record quarter of revenue growth, up 48% to $23bn, with Mounjaro and Zepbound now making up two-thirds of the total.
News Cavanaugh to replace Taubert as J&J's pharma head Jennifer Taubert will hand over the reins of Johnson & Johnson's Innovative Medicines division to Tom Cavanaugh after she retires on 1st September.
News ESMO26: Lily's sofe-m ADC stakes a claim in ovarian cancer Eli Lilly's first major readout at ESMO comes from a phase 1 trial of its FRα-targeting sofe-m in platinum-sensitive ovarian cancer (PSOC).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.